
AVGO
- Market cap
- $785B
- Sector
- Information technology

Stored run, base case: $158.01 · difference under 0.1%.
Value per share against today's price
The multiple the final year is sold at
Higher means a lower value
A year, for 10 years held
Sensitivity: discount rate × exit multiple
Value per share at each pairing. The outlined cell is the pairing the rail is set to.
| Exit multiple → | |||||
|---|---|---|---|---|---|
| Discount rate | 23.4× | 24.4× | 25.4× | 26.4× | 27.4× |
| 8.40% | $160.89 | $166.40 | $171.91 | $177.41 | $182.92 |
| 8.90% | $154.27 | $159.53 | $164.79 | $170.05 | $175.31 |
| 9.40% | $147.96 | $152.99 | $158.01 | $163.04 | $168.06 |
| 9.90% | $141.96 | $146.76 | $151.56 | $156.36 | $161.16 |
| 10.40% | $136.23 | $140.82 | $145.41 | $150.00 | $154.59 |
Both axes step around the rail's own settings, so the grid re-centres whenever you move one.
Exit multiple vs historical P/E
Exit multiple 25.4× vs the company's own multiple by fiscal year, oldest first.
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Company P/E | 22.0× | 26.6× | 31.0× | 35.3× | 39.3× |
| Exit 25.4× vs it | +15% | −4% | −18% | −28% | −35% |
Implied perpetual growth at 25.4×: 6.85%
The growth for ever, after year 10, at which the final year's dividend, discounted at 9.40%, is worth what the sale fetches.
Read against the dividend alone, so a low payout reads as a high rate: the sale is carrying earnings the dividend does not pay out.
Valuation build-up
Dollars per share.
| Per share | Share | Amount |
|---|---|---|
| Earnings per share, current | $4.28 | |
| Earnings per share, year 10 | $12.34 | |
| PV of exit value at 25.4× | 81% | $127.74 |
| PV of interim dividend | 19% | $30.27 |
| EV-to-equity bridge (per-share basis) | n/a | |
| Value per share | $158.01 |
Methodology
The same terminal sale run per share: earnings grown for ten years, sold at an exit multiple, dividends credited, discounted at the cost of equity.
| Construction | Recorded |
|---|---|
| Diluted earnings per share in 2036 | $12.34 |
| Multiple applied | 25.4× |
| Supported multiple range | 21.6× to 31.2×, median 25.4× |
| Holding period | 10 years |
| Phase-2 start | year 6 |
| Discount rate (cost of equity) | 9.40% |
| EV-to-equity bridge | n/a (per-share basis) |
| Value per share | $169.10 |
Scenarios and weights
Dollars per share. Each case moves the growth path and the multiple together, because a slower business sells for less.
| Case | Weight | Growth | Then | Sold at | Value per share | vs price |
|---|---|---|---|---|---|---|
| Negative | 20% | 6.7% | 4.0% | 21.6× | −49.2% | |
| Base | 60% | 14.0% | 8.4% | 25.4× | −6.1% | |
| Optimistic | 20% | 21.3% | 12.8% | 29.2× | +70.1% |
Weighted answer $169.10, which is the figure on this card.
Multiple rationale
Its own five-year average is 21.6× and the sector median is 31.2×; the choice sits at 25.4×, three parts the first and two parts the second. The size-ranked comparables run from 12.7× to 120.9× and set nothing here. Applied to diluted earnings per share in 2036, discounted once at 9.4%. Every case grows faster than the 11.2% this business can fund out of its own returns, which is a finding about the base case and not only about the optimistic one.
Its own five-year average and the sector median are the two benchmarks the relative-valuation tab publishes for the same ratio.
Size-matched comparables
Context only. None of these enters the multiple above.
| Company | Multiple | vs applied |
|---|---|---|
| TSLA Tesla | +376% | |
| JPM JPMorgan | −50% | |
| UNH UnitedHealth | −21% |